Literature DB >> 11156482

Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.

K Nakagawa1.   

Abstract

Ascorbyl radical (ASR) in human cerebrospinal fluid (CSF) of various patients using electron paramagnetic resonance (EPR) at ambient temperature was investigated. Also, effect of chemotherapy on ASR as well as ascorbate (ASA) in CSF and serum of acute lymphoblastic leukemia (ALL) was studied. EPR spectra of various CSF samples showed a characteristic doublet, which was attributed to ASR. ASR in CSF and serum was directly measured without any chemical modification. ASA and ASR concentration in CSF were approximately two times higher than those in serum. ASA and ASR concentrations in CSF and serum were statistically analyzed. The analyses showed that ASR and ASA in CSF and serum had good correlation for patients undergoing chemotherapy but not for patients after the therapy. The correlation for ASR and ASA suggests that ascorbate may play an important role during chemotherapy. In addition, dynamic aspects of ASA and ASR in CSF and serum are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156482

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

1.  Locations of radical species in black pepper seeds investigated by CW EPR and 9GHz EPR imaging.

Authors:  Kouichi Nakagawa; Boris Epel
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2014-04-30       Impact factor: 4.098

2.  Gene and Protein Expression Is Altered by Ascorbate Availability in Murine Macrophages Cultured under Tumour-Like Conditions.

Authors:  Abel D Ang; Margreet C M Vissers; Eleanor R Burgess; Margaret J Currie; Gabi U Dachs
Journal:  Antioxidants (Basel)       Date:  2021-03-11

Review 3.  Vitamin C and immune cell function in inflammation and cancer.

Authors:  Abel Ang; Juliet M Pullar; Margaret J Currie; Margreet C M Vissers
Journal:  Biochem Soc Trans       Date:  2018-10-08       Impact factor: 5.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.